epocrates logo
epocrates logo
epocrates logo
  • 0

Journal Article Synopsis

JAMA Intern Med

Use the PEN-FAST decision tool to delabel patients without true penicillin allergy

July 10, 2023

card-image

PEN-FAST scores of 2 or less had a negative predictive value of 100% in this retrospective study at a large tertiary healthcare system. The tool can identify patients whose low-risk “penicillin allergy” can be safety delabeled—without requiring skin testing prior to an oral penicillin challenge.

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus
Clinical FAQ icon

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information